Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like AmerisourceBergen Coughs Up $625M to Resolve U.S. Government Probe November 21, 2017 Dyadic Reports First Quarter 2017 Financial Results May 11, 2017 This $4 Billion Asian Drugmaker With U.S. Ops Just Went on the Market September 25, 2017
